Case study in VersKiK: a methodological approach for studying paediatric cancer survivors’ pathways
Ekaterina Aleshchenko(Otto-von-Guericke-Universität Magdeburg), Katja Baust(University Hospital Bonn), Gabriele Calaminus(University Hospital Bonn), Thorsten Langer, J. Glogner(University Hospital Bonn), Enno Swart(Otto-von-Guericke-Universität Magdeburg), Judith Gebauer(University Hospital Schleswig-Holstein)
Cited by 0
Related Papers
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
|The Lancet Oncology|2016|537
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
|Journal of Clinical Oncology|2015|419
Brief Internet-Based Intervention Reduces Posttraumatic Stress and Prolonged Grief in Parents after the Loss of a Child during Pregnancy: A Randomized Controlled Trial
|Psychotherapy and Psychosomatics|2013|220